Pratik Shah

Director, Ocera Therapeutics, Inc.

Companies

Design Therapeutics, Inc.Chief executive officer Sep 5, 2023 to now¹
Design Therapeutics, Inc.President Sep 5, 2023 to now¹
Silverback TherapeuticsBoard member Nov 10, 2022 to now²
Design Therapeutics, Inc.Chair Mar 25, 2021 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silverback Therapeutics SPRY4,474,554 shares⁴$18.1M at $4.04Nov 12, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 12, 2025Gift 100,000 shares of Silverback Therapeutics⁴
Nov 12, 2025Gift 250,000 shares of Silverback Therapeutics⁴
Jun 13, 2024Gift 1,132,900 shares of Silverback Therapeutics⁵
Jun 13, 2024Gift 200,000 shares of Silverback Therapeutics⁵
Jun 7, 2024Gift 1,332,950 shares of Silverback Therapeutics⁶
Jun 4, 2024Gift 1,332,900 shares of Silverback Therapeutics⁷
Jun 4, 2024Gift 1,332,900 shares of Silverback Therapeutics⁷
Jun 4, 2024Other 2,665,800 shares of Silverback Therapeutics⁷
Nov 8, 2022Granted 10,156,204 shares of Silverback Therapeutics⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDesign Therapeutics, Inc., Chief executive officer
2
SEC EDGARSilverback Therapeutics, Board member
3
SEC EDGARDesign Therapeutics, Inc., Chair
4
SEC EDGARSilverback Therapeutics shares after the filing of Nov 12, 2025
5
SEC EDGARForm 4 filed Jun 17, 2024
6
SEC EDGARForm 4 filed Jun 7, 2024
7
SEC EDGARForm 4 filed Jun 6, 2024
8
SEC EDGARForm 4 filed Nov 10, 2022